BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29390349)

  • 1. Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.
    Fujimoto S; Kawabata H; Kurose N; Kawanami-Iwao H; Sakai T; Kawanami T; Fujita Y; Fukushima T; Masaki Y
    Medicine (Baltimore); 2017 Dec; 96(50):e9220. PubMed ID: 29390349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review.
    Grange L; Chalayer E; Boutboul D; Paul S; Galicier L; Gramont B; Killian M
    Autoimmun Rev; 2022 Aug; 21(8):103137. PubMed ID: 35803499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TAFRO syndrome with primary Sjogren's syndrome].
    Iwanaga N; Harada K; Tsuji Y; Kawahara C; Kurohama K; Izumi Y; Yoshida S; Fujikawa K; Ito M; Kawakami A; Migita K
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):478-484. PubMed ID: 27795506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
    Fujiwara Y; Ito K; Takamura A; Nagata K
    J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.
    Kadoba K; Waki D; Nishimura K; Mukoyama H; Saito R; Murabe H; Yokota T
    Medicine (Baltimore); 2020 Oct; 99(42):e22793. PubMed ID: 33080751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
    Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
    Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined B-cell immunomodulation with rituximab and belimumab in severe, refractory TAFRO syndrome associated with Sjögren's syndrome: A case report.
    Watanabe M; Haji Y; Hozumi M; Amari Y; Mizuno Y; Ito T; Kato M; Okada M
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):475-479. PubMed ID: 37061843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
    Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
    Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6.
    Suzuki H; Sano T; Shimasaki Y; Yamaguchi M; Ide T; Arinaga-Hino T; Kuwahara R; Amano K; Oshima K; Nagafuji K; Ida H; Koga H; Torimura T
    Intern Med; 2022 Oct; 61(19):2967-2972. PubMed ID: 35228431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe systemic inflammation mimicking TAFRO syndrome following COVID-19.
    Tane M; Kosako H; Hosoi H; Tabata K; Hiroi T; Osawa K; Iwamoto R; Murata S; Mushino T; Murata SI; Araki SI; Fujii T; Sonoki T
    Int J Hematol; 2023 Sep; 118(3):374-380. PubMed ID: 37000328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenia, Anasarca, Myelofibrosis, Renal dysfunction, and Organomegaly (TAFRO) Syndrome Initially Diagnosed as Fibromyalgia: A Case Report.
    Ohta R; Sano C
    Cureus; 2023 Jul; 15(7):e42514. PubMed ID: 37637539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
    Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
    J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
    Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
    J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAFRO Syndrome.
    Igawa T; Sato Y
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.